Oral Antidiabetic Agents Market, Global Outlook and Forecast 2023-2028

Report ID: 1372447 | Published Date: Jan 2025 | No. of Page: 64 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Oral Antidiabetic Agents Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Oral Antidiabetic Agents Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Oral Antidiabetic Agents Overall Market Size
    2.1 Global Oral Antidiabetic Agents Market Size: 2021 VS 2028
    2.2 Global Oral Antidiabetic Agents Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Oral Antidiabetic Agents Players in Global Market
    3.2 Top Global Oral Antidiabetic Agents Companies Ranked by Revenue
    3.3 Global Oral Antidiabetic Agents Revenue by Companies
    3.4 Top 3 and Top 5 Oral Antidiabetic Agents Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Oral Antidiabetic Agents Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Oral Antidiabetic Agents Players in Global Market
        3.6.1 List of Global Tier 1 Oral Antidiabetic Agents Companies
        3.6.2 List of Global Tier 2 and Tier 3 Oral Antidiabetic Agents Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Oral Antidiabetic Agents Market Size Markets, 2021 & 2028
        4.1.2 Sulfonylureas
        4.1.3 Meglitinides
        4.1.4 Biguanides
        4.1.5 Thiazolidinediones
        4.1.6 Alpha-glucosidase Inhibitors
    4.2 By Type - Global Oral Antidiabetic Agents Revenue & Forecasts
        4.2.1 By Type - Global Oral Antidiabetic Agents Revenue, 2017-2022
        4.2.2 By Type - Global Oral Antidiabetic Agents Revenue, 2023-2028
        4.2.3 By Type - Global Oral Antidiabetic Agents Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Oral Antidiabetic Agents Market Size, 2021 & 2028
        5.1.2 Home Use
        5.1.3 Medical Institutions
        5.1.4 Others
    5.2 By Application - Global Oral Antidiabetic Agents Revenue & Forecasts
        5.2.1 By Application - Global Oral Antidiabetic Agents Revenue, 2017-2022
        5.2.2 By Application - Global Oral Antidiabetic Agents Revenue, 2023-2028
        5.2.3 By Application - Global Oral Antidiabetic Agents Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Oral Antidiabetic Agents Market Size, 2021 & 2028
    6.2 By Region - Global Oral Antidiabetic Agents Revenue & Forecasts
        6.2.1 By Region - Global Oral Antidiabetic Agents Revenue, 2017-2022
        6.2.2 By Region - Global Oral Antidiabetic Agents Revenue, 2023-2028
        6.2.3 By Region - Global Oral Antidiabetic Agents Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Oral Antidiabetic Agents Revenue, 2017-2028
        6.3.2 US Oral Antidiabetic Agents Market Size, 2017-2028
        6.3.3 Canada Oral Antidiabetic Agents Market Size, 2017-2028
        6.3.4 Mexico Oral Antidiabetic Agents Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Oral Antidiabetic Agents Revenue, 2017-2028
        6.4.2 Germany Oral Antidiabetic Agents Market Size, 2017-2028
        6.4.3 France Oral Antidiabetic Agents Market Size, 2017-2028
        6.4.4 U.K. Oral Antidiabetic Agents Market Size, 2017-2028
        6.4.5 Italy Oral Antidiabetic Agents Market Size, 2017-2028
        6.4.6 Russia Oral Antidiabetic Agents Market Size, 2017-2028
        6.4.7 Nordic Countries Oral Antidiabetic Agents Market Size, 2017-2028
        6.4.8 Benelux Oral Antidiabetic Agents Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Oral Antidiabetic Agents Revenue, 2017-2028
        6.5.2 China Oral Antidiabetic Agents Market Size, 2017-2028
        6.5.3 Japan Oral Antidiabetic Agents Market Size, 2017-2028
        6.5.4 South Korea Oral Antidiabetic Agents Market Size, 2017-2028
        6.5.5 Southeast Asia Oral Antidiabetic Agents Market Size, 2017-2028
        6.5.6 India Oral Antidiabetic Agents Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Oral Antidiabetic Agents Revenue, 2017-2028
        6.6.2 Brazil Oral Antidiabetic Agents Market Size, 2017-2028
        6.6.3 Argentina Oral Antidiabetic Agents Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Oral Antidiabetic Agents Revenue, 2017-2028
        6.7.2 Turkey Oral Antidiabetic Agents Market Size, 2017-2028
        6.7.3 Israel Oral Antidiabetic Agents Market Size, 2017-2028
        6.7.4 Saudi Arabia Oral Antidiabetic Agents Market Size, 2017-2028
        6.7.5 UAE Oral Antidiabetic Agents Market Size, 2017-2028
7 Players Profiles
    7.1 Novo Nordisk
        7.1.1 Novo Nordisk Corporate Summary
        7.1.2 Novo Nordisk Business Overview
        7.1.3 Novo Nordisk Oral Antidiabetic Agents Major Product Offerings
        7.1.4 Novo Nordisk Oral Antidiabetic Agents Revenue in Global Market (2017-2022)
        7.1.5 Novo Nordisk Key News
    7.2 Eli Lilly
        7.2.1 Eli Lilly Corporate Summary
        7.2.2 Eli Lilly Business Overview
        7.2.3 Eli Lilly Oral Antidiabetic Agents Major Product Offerings
        7.2.4 Eli Lilly Oral Antidiabetic Agents Revenue in Global Market (2017-2022)
        7.2.5 Eli Lilly Key News
    7.3 Sanofi
        7.3.1 Sanofi Corporate Summary
        7.3.2 Sanofi Business Overview
        7.3.3 Sanofi Oral Antidiabetic Agents Major Product Offerings
        7.3.4 Sanofi Oral Antidiabetic Agents Revenue in Global Market (2017-2022)
        7.3.5 Sanofi Key News
    7.4 Roche
        7.4.1 Roche Corporate Summary
        7.4.2 Roche Business Overview
        7.4.3 Roche Oral Antidiabetic Agents Major Product Offerings
        7.4.4 Roche Oral Antidiabetic Agents Revenue in Global Market (2017-2022)
        7.4.5 Roche Key News
    7.5 Teva
        7.5.1 Teva Corporate Summary
        7.5.2 Teva Business Overview
        7.5.3 Teva Oral Antidiabetic Agents Major Product Offerings
        7.5.4 Teva Oral Antidiabetic Agents Revenue in Global Market (2017-2022)
        7.5.5 Teva Key News
    7.6 AstraZeneca
        7.6.1 AstraZeneca Corporate Summary
        7.6.2 AstraZeneca Business Overview
        7.6.3 AstraZeneca Oral Antidiabetic Agents Major Product Offerings
        7.6.4 AstraZeneca Oral Antidiabetic Agents Revenue in Global Market (2017-2022)
        7.6.5 AstraZeneca Key News
    7.7 Wockhardt UK
        7.7.1 Wockhardt UK Corporate Summary
        7.7.2 Wockhardt UK Business Overview
        7.7.3 Wockhardt UK Oral Antidiabetic Agents Major Product Offerings
        7.7.4 Wockhardt UK Oral Antidiabetic Agents Revenue in Global Market (2017-2022)
        7.7.5 Wockhardt UK Key News
    7.8 Merck
        7.8.1 Merck Corporate Summary
        7.8.2 Merck Business Overview
        7.8.3 Merck Oral Antidiabetic Agents Major Product Offerings
        7.8.4 Merck Oral Antidiabetic Agents Revenue in Global Market (2017-2022)
        7.8.5 Merck Key News
    7.9 Pfizer
        7.9.1 Pfizer Corporate Summary
        7.9.2 Pfizer Business Overview
        7.9.3 Pfizer Oral Antidiabetic Agents Major Product Offerings
        7.9.4 Pfizer Oral Antidiabetic Agents Revenue in Global Market (2017-2022)
        7.9.5 Pfizer Key News
    7.10 Cipla
        7.10.1 Cipla Corporate Summary
        7.10.2 Cipla Business Overview
        7.10.3 Cipla Oral Antidiabetic Agents Major Product Offerings
        7.10.4 Cipla Oral Antidiabetic Agents Revenue in Global Market (2017-2022)
        7.10.5 Cipla Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Oral Antidiabetic Agents Market Opportunities & Trends in Global Market
    Table 2. Oral Antidiabetic Agents Market Drivers in Global Market
    Table 3. Oral Antidiabetic Agents Market Restraints in Global Market
    Table 4. Key Players of Oral Antidiabetic Agents in Global Market
    Table 5. Top Oral Antidiabetic Agents Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Oral Antidiabetic Agents Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Oral Antidiabetic Agents Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Oral Antidiabetic Agents Product Type
    Table 9. List of Global Tier 1 Oral Antidiabetic Agents Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Oral Antidiabetic Agents Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Oral Antidiabetic Agents Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Oral Antidiabetic Agents Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Oral Antidiabetic Agents Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Oral Antidiabetic Agents Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Oral Antidiabetic Agents Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Oral Antidiabetic Agents Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Oral Antidiabetic Agents Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Oral Antidiabetic Agents Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Oral Antidiabetic Agents Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Oral Antidiabetic Agents Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Oral Antidiabetic Agents Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Oral Antidiabetic Agents Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Oral Antidiabetic Agents Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Oral Antidiabetic Agents Revenue, (US$, Mn), 2023-2028
    Table 30. Novo Nordisk Corporate Summary
    Table 31. Novo Nordisk Oral Antidiabetic Agents Product Offerings
    Table 32. Novo Nordisk Oral Antidiabetic Agents Revenue (US$, Mn), (2017-2022)
    Table 33. Eli Lilly Corporate Summary
    Table 34. Eli Lilly Oral Antidiabetic Agents Product Offerings
    Table 35. Eli Lilly Oral Antidiabetic Agents Revenue (US$, Mn), (2017-2022)
    Table 36. Sanofi Corporate Summary
    Table 37. Sanofi Oral Antidiabetic Agents Product Offerings
    Table 38. Sanofi Oral Antidiabetic Agents Revenue (US$, Mn), (2017-2022)
    Table 39. Roche Corporate Summary
    Table 40. Roche Oral Antidiabetic Agents Product Offerings
    Table 41. Roche Oral Antidiabetic Agents Revenue (US$, Mn), (2017-2022)
    Table 42. Teva Corporate Summary
    Table 43. Teva Oral Antidiabetic Agents Product Offerings
    Table 44. Teva Oral Antidiabetic Agents Revenue (US$, Mn), (2017-2022)
    Table 45. AstraZeneca Corporate Summary
    Table 46. AstraZeneca Oral Antidiabetic Agents Product Offerings
    Table 47. AstraZeneca Oral Antidiabetic Agents Revenue (US$, Mn), (2017-2022)
    Table 48. Wockhardt UK Corporate Summary
    Table 49. Wockhardt UK Oral Antidiabetic Agents Product Offerings
    Table 50. Wockhardt UK Oral Antidiabetic Agents Revenue (US$, Mn), (2017-2022)
    Table 51. Merck Corporate Summary
    Table 52. Merck Oral Antidiabetic Agents Product Offerings
    Table 53. Merck Oral Antidiabetic Agents Revenue (US$, Mn), (2017-2022)
    Table 54. Pfizer Corporate Summary
    Table 55. Pfizer Oral Antidiabetic Agents Product Offerings
    Table 56. Pfizer Oral Antidiabetic Agents Revenue (US$, Mn), (2017-2022)
    Table 57. Cipla Corporate Summary
    Table 58. Cipla Oral Antidiabetic Agents Product Offerings
    Table 59. Cipla Oral Antidiabetic Agents Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Oral Antidiabetic Agents Segment by Type in 2021
    Figure 2. Oral Antidiabetic Agents Segment by Application in 2021
    Figure 3. Global Oral Antidiabetic Agents Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Oral Antidiabetic Agents Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Oral Antidiabetic Agents Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Oral Antidiabetic Agents Revenue in 2021
    Figure 8. By Type - Global Oral Antidiabetic Agents Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Oral Antidiabetic Agents Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Oral Antidiabetic Agents Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Oral Antidiabetic Agents Revenue Market Share, 2017-2028
    Figure 12. US Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Oral Antidiabetic Agents Revenue Market Share, 2017-2028
    Figure 16. Germany Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 17. France Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Oral Antidiabetic Agents Revenue Market Share, 2017-2028
    Figure 24. China Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 28. India Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Oral Antidiabetic Agents Revenue Market Share, 2017-2028
    Figure 30. Brazil Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Oral Antidiabetic Agents Revenue Market Share, 2017-2028
    Figure 33. Turkey Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Oral Antidiabetic Agents Revenue, (US$, Mn), 2017-2028
    Figure 37. Novo Nordisk Oral Antidiabetic Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Eli Lilly Oral Antidiabetic Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Sanofi Oral Antidiabetic Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Roche Oral Antidiabetic Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Teva Oral Antidiabetic Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. AstraZeneca Oral Antidiabetic Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Wockhardt UK Oral Antidiabetic Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Merck Oral Antidiabetic Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Pfizer Oral Antidiabetic Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Cipla Oral Antidiabetic Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
64
Frequently Asked Questions
Oral Antidiabetic Agents Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oral Antidiabetic Agents Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oral Antidiabetic Agents Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports